MELISSA LARSON: Open Payments
NPI 1336625409 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,786 in 88 payments from 18 companies in 2025. Trend: 2023 $1,588 · 2024 $2,008 · 2025 $1,786
Food & beverage: $1,786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $495 |
| Janssen Biotech, Inc. | 23 | $333 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $189 |
| GENZYME CORPORATION | 6 | $166 |
| Lilly USA, LLC | 2 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Boston Scientific Corporation | 1 | $84 |
| Madrigal Pharmaceuticals | 2 | $53 |
| Gilead Sciences, Inc. | 2 | $47 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, ZEPBOUND, MAVYRET, Axios, CREON.
Industry payments across IN — which companies pay providers there.
